DarioHealth
DRIO
58 hedge funds and large institutions have $58M invested in DarioHealth in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 19 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 17
7.46% less ownership
Funds ownership: 50.42% → 42.96% (-7.5%)
8% less funds holding
Funds holding: 63 → 58 (-5)
21% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 19
54% less capital inflows, than outflows
Capital inflows: $7.42M | Capital outflows: $16M
54% less call options, than puts
Call options by funds: $262K | Put options by funds: $570K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.52M |
| 2 |
MAI Capital Management
Independence,
Ohio
|
+$2.04M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$393K |
| 4 |
E
Ergoteles
New York
|
+$328K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$319K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.8M |
| 2 |
L1 Capital
Melbourne VIC 3000,
Australia
|
-$3.18M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.6M |
| 4 |
Collaborative Holdings Management
New York
|
-$1.57M |
| 5 |
Farallon Capital Management
San Francisco,
California
|
-$777K |
DRIO Hedge Fund Activity: Q2 2022 in Review
58 of the 5,963 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q2 2022, worth a combined $58M — down 9% from $63.7M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of DRIO and 15 opened new positions — a net loss of 4 holders — while 17 trimmed existing stakes and 16 added.
The largest buyer was Millennium Management, adding an estimated $2.52M. The largest seller was BlackRock, cutting an estimated $3.8M.
- 58 institutional investors held DarioHealth (DRIO) as of Q2 2022, down from 63 in Q1 2022.
- Funds reported $58M of DarioHealth stock for Q2 2022, down 9% quarter-over-quarter.
- 15 funds opened new DarioHealth positions in Q2 2022 and 19 closed out, a net change of -4 holders.
- The largest DarioHealth buyer in Q2 2022 was Millennium Management, an estimated $2.52M added.
- The largest DarioHealth seller in Q2 2022 was BlackRock, an estimated $3.8M sold.
Based on aggregated 13F filings for Q2 2022.